(Q40432929)

English

The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15842252%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

Peter F Randerson

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

author name string

A Al-Hazzaa

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

I D Bowen

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

M A Birchall

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15842252%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Cell Proliferation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

38

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

77-86

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

Improved cytochemical methods for demonstrating cell death using LR White as an embedding medium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

New directions for ZD1839 in the treatment of solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2005.00332.X

21 January 2018

Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why the epidermal growth factor receptor? The rationale for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis, angiogenesis and proliferation: trifunctional measure of tumour response to radiotherapy for oral cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis in head-and-neck squamous carcinoma cells by gamma-irradiation and bleomycin is p53-independent

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is cisplatin-induced cell death always produced by apoptosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of cisplatin sensitivity with differential alteration of EGFR expression in head and neck cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15842252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2184.2005.00332.X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6760735&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40432929&oldid=1493535759"